| Dr Mary M Oconnor, DO | |
|
5701 Bow Pointe Dr Ste 365, Clarkston, MI 48346 | |
| (248) 922-9283 | |
| (248) 922-9286 |
| Full Name | Dr Mary M Oconnor |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 5701 Bow Pointe Dr Ste 365, Clarkston, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851401129 | NPI | - | NPPES |
| 4834181-11 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 5101015287 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Huron Valley-sinai Hospital | Commerce township, MI | Hospital |
| St Joseph Mercy Oakland | Pontiac, MI | Hospital |
| Mclaren Oakland | Pontiac, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary And Critical Care Medicine Consultants Pc | 3870527443 | 5 |
News Archive
In a paper appearing online in advance of print publication of the October 1 issue of the Journal of Clinical Investigation, Adam Boruchov and colleagues from Memorial Sloan Kettering Cancer Center dissect the contributions of CD32 isoforms in human dendritic cell (DC) activation and function.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
The pandemic of COVID-19 that is still affecting over 188 countries and territories the world over has taken over 359,000 lives in just under five months, while affecting at least 5.8 million people. Different strains have diverged from the original strain detected in Wuhan, China.
USA Today examines several scientific breakthroughs that researchers say "could be key to reducing new HIV infections." "Doctors are hopeful not because of a single discovery, but because of a string of breakthroughs over the past two or three years, says Diane Havlir, a professor at the University of California-San Francisco," the news service writes.
› Verified 8 days ago
| Entity Name | Pulmonary & Critical Care Medicine Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851330773 PECOS PAC ID: 3870527443 Enrollment ID: O20050922000887 |
News Archive
In a paper appearing online in advance of print publication of the October 1 issue of the Journal of Clinical Investigation, Adam Boruchov and colleagues from Memorial Sloan Kettering Cancer Center dissect the contributions of CD32 isoforms in human dendritic cell (DC) activation and function.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
The pandemic of COVID-19 that is still affecting over 188 countries and territories the world over has taken over 359,000 lives in just under five months, while affecting at least 5.8 million people. Different strains have diverged from the original strain detected in Wuhan, China.
USA Today examines several scientific breakthroughs that researchers say "could be key to reducing new HIV infections." "Doctors are hopeful not because of a single discovery, but because of a string of breakthroughs over the past two or three years, says Diane Havlir, a professor at the University of California-San Francisco," the news service writes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mary M Oconnor, DO 5701 Bow Pointe Dr Ste 365, Clarkston, MI 48346-5403 Ph: (248) 922-9283 | Dr Mary M Oconnor, DO 5701 Bow Pointe Dr Ste 365, Clarkston, MI 48346 Ph: (248) 922-9283 |
News Archive
In a paper appearing online in advance of print publication of the October 1 issue of the Journal of Clinical Investigation, Adam Boruchov and colleagues from Memorial Sloan Kettering Cancer Center dissect the contributions of CD32 isoforms in human dendritic cell (DC) activation and function.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
The pandemic of COVID-19 that is still affecting over 188 countries and territories the world over has taken over 359,000 lives in just under five months, while affecting at least 5.8 million people. Different strains have diverged from the original strain detected in Wuhan, China.
USA Today examines several scientific breakthroughs that researchers say "could be key to reducing new HIV infections." "Doctors are hopeful not because of a single discovery, but because of a string of breakthroughs over the past two or three years, says Diane Havlir, a professor at the University of California-San Francisco," the news service writes.
› Verified 8 days ago
Dr. Daniel N Haddad, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5701 Bow Pointe Dr Ste 100, Clarkston, MI 48346 Phone: 248-625-2621 Fax: 248-625-2622 | |
Nehal Altaie, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5625 Water Tower Pl Ste 210, Clarkston, MI 48346 Phone: 248-625-1011 Fax: 248-625-0226 | |
Dr. Scott Simecek Ii, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5701 Bow Pointe Dr, Ste 365, Clarkston, MI 48346 Phone: 248-922-9283 Fax: 248-922-9286 | |
Michael J Baker, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5701 Bow Pointe Drive, Suite 100, Clarkston, MI 48346 Phone: 248-625-2621 Fax: 628-625-2622 | |
Dr. Kathryn Mcgee Hinderer, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5701 Bow Pointe Dr Ste 100, Clarkston, MI 48346 Phone: 248-625-2621 Fax: 248-625-2622 | |
Dr. Naveen Gunda Reddy, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5701 Bow Pointe Dr, Suite 370, Clarkston, MI 48346 Phone: 248-625-4055 Fax: 248-625-4085 | |
Ramy Mansour, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5701 Bow Pointe Dr Ste 370, Clarkston, MI 48346 Phone: 248-625-4055 |